Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Shanghai Ruishi Health Technology

Request full access

Manufactures massage products

Huangpu, ChinaFounded 2017Wellness Beauty

About Shanghai Ruishi Health Technology

Shanghai Ruishi Health Technology Co., Ltd., operating as Ruishi Technology, is a health-tech firm established on May 19, 2017. The company focuses on the prevention and control of myopia in children and adolescents. Since its inception, Ruishi Technology has secured significant funding to support its growth and research initiatives. In December 2022, the company raised 50 million RMB in a Series A round from Bluerun Ventures and Yaojin Capital. This was followed by a substantial Series A+ round in August 2023, raising hundreds of millions of RMB from investors including Sinovation Ventures, Betaine, Yaojin Capital, and Bluerun Ventures. Most recently, in June 2025, it secured tens of millions of RMB in a Series A++ round led by Jinke Junchuang.

The company's core product is the Ruishi Distant Vision Screen, developed under the guidance of chief scientist Professor Wang Ningli, a co-inventor of the underlying technology. This device is engineered to address the root causes of myopia in young users. It employs a combination of three key technologies: simulated high-definition distant imaging, digital spectral structure, and digital defocus with blur stimulation. By integrating patented AR free-form surface technology, the screen projects a magnified, high-definition image that simulates viewing objects at a distance. This setup allows children to engage with digital learning and entertainment content without the eye strain associated with prolonged near-distance focus, thereby helping to prevent transient myopia and reduce visual fatigue. The product has been recognized with an award for scientific and technological progress in ophthalmology.

Ruishi Technology serves the expansive market for children's vision health, a significant concern given the rising prevalence of myopia. The business model appears to be centered on the sale of its specialized hardware, the Distant Vision Screen, to families and potentially educational institutions. The company's legal representative is Pan Dejiao, and a major shareholder is Yao Jun. Formerly known as Shanghai Nuanwen Information Technology Co., Ltd., the company leverages a potent mix of IoT, artificial intelligence, and big data to deliver its vision health management services.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
19.7/100
Industry
Wellness Beauty
Sector
Hard Tech
Business model
Manufacturing
Client focus
B2B, B2C
Investment activity
1 company, latest Mar 2022
Capital deployed
$0
Preferred round
SEED
Links
Website

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Aug 2025 $2.8M $69M Sinovation Ventures · Huaxi Securities · Chuangxin Gongchang ↗
SERIES A✓Equity / VC Jun 2025 $2.8M $69M JC Capital ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Shanghai Ruishi Health Technology website traffic

Latest recorded traffic for Shanghai Ruishi Health Technology is 300 monthly website visits, down 11.8% over the last three months.

Latest monthly visits300 3-month web change-11.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Shanghai Ruishi Health Technology in the Huangpu ecosystem

Live from Dealroom

The Shanghai Ruishi Health Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A8 investors entered at this stage

  • Sinopharm CICC
  • Lanchi Ventures
  • Chuangxin Gongchang
  • Yaojin Capital
  • Yunnan Botanee Bio-Tech Group
  • JC Capital
  • Sinovation Ventures
  • Huaxi Securities
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Huangpu HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Shanghai Ruishi Health Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Shanghai Ruishi Health Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.